Evaluation of drug efficacy in a RAT model of neuropathic pain
Ended Awarded Last action
- Contract number
- 75N95019F00090
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $292,814
Award facts
- Opportunity
-
- CRO Support for NCATS Animal Model Development and In Vivo Pharmacology Studies and Related Services Pre-Solicitation · N01TR192005 · Posted Mar 13, 2018
- Contract value 56% obligated
-
- $292,813.73 Current, with exercised options
- $520,896.73 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$63,192 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $356,006 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $520,896.73 contract is for the evaluation of drug efficacy in a rat model of neuropathic pain. Lovelace Biomedical Research Institute has experience conducting animal studies, including for federal agencies like NIH, the Department of Defense, and the Department of Health and Human Services. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95019F00090?
75N95019F00090 was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 24, 2019.
How much is contract 75N95019F00090 worth?
The government has obligated $292,814 on 75N95019F00090. Its potential value, with all options, is $520,897.
Which agency awarded contract 75N95019F00090?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019F00090, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95019F00090 an order under another contract?
Yes. 75N95019F00090 is a delivery order under 75N95019D00012, an indefinite delivery contract.
Was contract 75N95019F00090 competed?
The extent of competition for 75N95019F00090 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award